Trademarkia Logo

Canada

C$
Trademark Search in Canada
STANTALA

View On IC.GC.CA

STANTALA
REGISTERED

on 20 Dec 2019

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001

US

Serial Number

1866897 filed on 8th Nov 2017

Registration Number

TMA1067150 registered on 20th Dec 2019

Registration expiry Date

20th Dec 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

STANTALA

Trademark usage description

human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases including pulmonary hypertension, Read More

Classification Information

Class [005]
Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases including pulmonary hypertension, pulmonary arterial hypertension, respiratory diseases including treatments of allergies and allergic responses; human pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases, oncologic diseases, ophthalmic diseases; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of central nervous systems diseases, namely neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of central nervous systems diseases, namely human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for the prevention and treatment of central nervous systems diseases, namely anxiolytic medications; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-virals, including for the prevention and treatment of HIV, anti-inflammatories, anti-infectives, and human vaccines; human pharmaceutical preparations for the relief of pain

Classification kind code

11

Mark Details

Serial Number

1866897

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 18th Dec 2019		Registration Pending
Submitted for opposition 191
on 18th Dec 2019		Registration Fee Notice Sent
Submitted for opposition 42
on 7th Aug 2019		Advertised
Submitted for opposition 26
on 18th Jul 2019		Approved
Submitted for opposition 27
on 30th May 2019		Approval Notice Sent
Submitted for opposition 22
on 13th Dec 2018		Search Recorded
Submitted for opposition 20
on 13th Dec 2018		Examiner's First Report
Submitted for opposition 31
on 14th Nov 2017		Formalized
Submitted for opposition 30
on 8th Nov 2017		Filed
Submitted for opposition 1
on 8th Nov 2017		Created